α-Glucosidase inhibition by flavonoids: an in vitro and in silico structure-activity relationship study

  • J Enzyme Inhib Med Chem. 2017 Dec;32(1):1216-1228. doi: 10.1080/14756366.2017.1368503.
Carina Proença  1 ,  Marisa Freitas  1 ,  Daniela Ribeiro  1 ,  Eduardo F T Oliveira  2 ,  Joana L C Sousa  3 ,  Sara M Tomé  3 ,  Maria J Ramos  2 ,  Artur M S Silva  3 ,  Pedro A Fernandes  2 ,  Eduarda Fernandes  1
Affiliations
  • 1. a UCIBIO, REQUIMTE, Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy , University of Porto , Porto , Portugal.
  • 2. b UCIBIO, REQUIMTE, Faculty of Sciences, Department of Chemistry and Biochemistry , University of Porto , Porto , Portugal.
  • 3. c Department of Chemistry & QOPNA , University of Aveiro , Aveiro , Portugal.
PMID: 28933564 DOI: 10.1080/14756366.2017.1368503
Abstract

α-Glucosidase inhibitors are described as the most effective in reducing post-prandial hyperglycaemia (PPHG) from all available anti-diabetic drugs used in the management of type 2 diabetes mellitus. As Flavonoids are promising modulators of this enzyme's activity, a panel of 44 Flavonoids, organised in five groups, was screened for their inhibitory activity of α-glucosidase, based on in vitro structure-activity relationship studies. Inhibitory kinetic analysis and molecular docking calculations were also applied for selected compounds. A flavonoid with two catechol groups in A- and B-rings, together with a 3-OH group at C-ring, was the most active, presenting an IC50 much lower than the one found for the most widely prescribed α-glucosidase inhibitor, acarbose. The present work suggests that several of the studied Flavonoids have the potential to be used as alternatives for the regulation of PPHG.

Keywords
Diabetes; flavonoids; in silico; in vitro; α-glucosidase inhibition.
Products